Where the category stands in May 2026 — what's available, who to trust, what costs what. 22-min read, medically reviewed.
Read the guideAn independent overview of the compounded-GLP-1 telehealth market and the providers we cover — market size, what the FDA changed, and an honest read on each.
View the provider overviewOverview & reviewsPrimers for newcomers and deep dives for the curious. The foundation articles are published; more are in the pipeline.
View all Learn articlesWhat compounded and branded semaglutide and tirzepatide actually cost, from each provider's own published pricing.
Two free tools to help you decide with data, not hype: match your goal to a peptide, and see what treatment actually costs. Below them, where to go next across the site.
Answer four questions and get the most-studied peptide for your goal, with links to our independent guides and provider reviews.
What compounded and branded semaglutide and tirzepatide actually cost — every figure taken from the provider's own published pricing, normalized to all-in cost per month and per mg, with the date it was captured.
Free to use · Medically reviewed methodology · How we build our tools
Not tools — the editorial sections these connect to.
Editorial head-to-heads — mechanism, efficacy, safety, and which to choose. Sourced from trials and primary data.
Why peptide access differs by state — telehealth rules, pharmacy licensing, and scope of practice.
The science, safety, and regulatory background — primers and deep dives across peptide therapy.
Independent, editorial reviews of the telehealth providers and clinics that prescribe these therapies.